• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX 33.3% 0.2¢

INVION LIMITED - News & Media

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No News & Media currently available.

(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $20.29M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $7.612K 3.753M

Buyers (Bids)

No. Vol. Price($)
7 5729449 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 12383990 52
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
Last
0.2¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.2¢ 0.2¢ 0.2¢ 53063
Last updated 15.58pm 15/11/2024 ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.